Pentolair
Pentolair Brand names, Pentolair Analogs
Pentolair Brand Names Mixture
- No information avaliable
Pentolair Chemical_Formula
C17H25NO3
Pentolair RX_link
No information avaliable
Pentolair fda sheet
Pentolair msds (material safety sheet)
Pentolair Synthesis Reference
No information avaliable
Pentolair Molecular Weight
291.385 g/mol
Pentolair Melting Point
139 oC (hydrochloride salt)
Pentolair H2O Solubility
No information avaliable
Pentolair State
Solid
Pentolair LogP
3.124
Pentolair Dosage Forms
Ophthalmic solution (eye drops)
Pentolair Indication
Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Pentolair Pharmacology
Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.
Pentolair Absorption
Absorbed following ophthalmic administration.
Pentolair side effects and Toxicity
Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.
Pentolair Patient Information
No information avaliable
Pentolair Organisms Affected
Humans and other mammals
